TY - JOUR
T1 - Tissue tolerance to reirradiation
AU - Nieder, Carsten
AU - Milas, Luka
AU - Ang, K. Kian
N1 - Funding Information:
From the Department of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX. Supported in part by Research Grants CA~06294 and CA-16672~om the National Cqncer Institute, National Institute of Health, and the Gilbert H. Fletcher C!tair. Address reprint requests to K. Klan Ang, MD, PhD, Department of Radiation, Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 97, Houston, TX 77030. Copyright 9 2000 by W.B. Saunders Company 1053-4296/00/1003-0004510.00/0 doi:l O.l O53/srao.2000.6593
PY - 2000
Y1 - 2000
N2 - There are increasing requests for delivering a second course of radiation to patients who develop second primary tumors within or close to previous radiotherapy portal or late in-field recurrences. Rational treatment decisions demand rather precise knowledge on long-term recovery of occult radiation injury in various organs. This article summarizes available experimental and clinical data on the effects of reirradiation to the skin, mucosa, gut, lung, spinal cord, brain, heart, bladder, and kidney. The data reveal that, in general, acutely responding tissues recover radiation injury within a few months and, therefore, can tolerate another full course of radiation. For late toxicity endpoints, however, tissues vary considerably in their capacity to recover from occult radiation damage. The heart, bladder, and kidney do not exhibit long-term recovery at all. In contrast, the skin, mucosa, lung, and spinal cord do recover subclinical injury partially to a magnitude dependent on the organ type, size of the initial dose, and, to a lesser extent, the interval between radiation courses. The available clinical data have inspired many radiation oncologists to undertake systematic studies addressing the efficacy and toxicity of reirradiation in various clinical settings. Hopefully, systematic scoring, collection, and analysis of patient outcome will produce quantitative data useful for clinical practice. Copyright (C) 2000 by W.B. Saunders Company.
AB - There are increasing requests for delivering a second course of radiation to patients who develop second primary tumors within or close to previous radiotherapy portal or late in-field recurrences. Rational treatment decisions demand rather precise knowledge on long-term recovery of occult radiation injury in various organs. This article summarizes available experimental and clinical data on the effects of reirradiation to the skin, mucosa, gut, lung, spinal cord, brain, heart, bladder, and kidney. The data reveal that, in general, acutely responding tissues recover radiation injury within a few months and, therefore, can tolerate another full course of radiation. For late toxicity endpoints, however, tissues vary considerably in their capacity to recover from occult radiation damage. The heart, bladder, and kidney do not exhibit long-term recovery at all. In contrast, the skin, mucosa, lung, and spinal cord do recover subclinical injury partially to a magnitude dependent on the organ type, size of the initial dose, and, to a lesser extent, the interval between radiation courses. The available clinical data have inspired many radiation oncologists to undertake systematic studies addressing the efficacy and toxicity of reirradiation in various clinical settings. Hopefully, systematic scoring, collection, and analysis of patient outcome will produce quantitative data useful for clinical practice. Copyright (C) 2000 by W.B. Saunders Company.
UR - https://www.scopus.com/pages/publications/0033949824
UR - https://www.scopus.com/pages/publications/0033949824#tab=citedBy
U2 - 10.1053/srao.2000.6593
DO - 10.1053/srao.2000.6593
M3 - Article
C2 - 11034631
AN - SCOPUS:0033949824
SN - 1053-4296
VL - 10
SP - 200
EP - 209
JO - Seminars in radiation oncology
JF - Seminars in radiation oncology
IS - 3
ER -